N. Kamei

发表

Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.

N. Kamei, Ebbe Juel Bech Nielsen, Takayuki Nakakubo, 2016, Journal of pharmaceutical sciences.

Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin.

N. Kamei, M. Takeda-Morishita, Satoshi Kawano, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Hydrophobic Amino Acid Tryptophan Shows Promise as a Potential Absorption Enhancer for Oral Delivery of Biopharmaceuticals

N. Kamei, M. Takeda-Morishita, Serena Hirano, 2018, Pharmaceutics.

Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.

Noriyasu Kamei, Kozo Takayama, Mariko Morishita, 2008, Journal of controlled release : official journal of the Controlled Release Society.

One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.

N. Kamei, M. Takeda-Morishita, R. Nishio, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Evaluation of Cell-Penetrating Peptides as Versatile, Effective Absorption Enhancers: Relation to Molecular Weight and Inherent Epithelial Drug Permeability

N. Kamei, M. Takeda-Morishita, Hideyuki Tamiwa, 2020, Pharmaceutical Research.

Noncovalent Strategy with Cell-Penetrating Peptides to Facilitate the Brain Delivery of Insulin through the Blood-Brain Barrier.

N. Kamei, M. Takeda-Morishita, Ai Yamaoka, 2018, Biological & pharmaceutical bulletin.

Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.

N. Kamei, Yukina Aoyama, M. Takeda-Morishita, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides.

N. Kamei, M. Takeda-Morishita, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps.

N. Kamei, M. Takeda-Morishita, Shingo Kikuchi, 2013, Journal of pharmaceutical sciences.

Cell-penetrating Peptide-biodrug Strategy for Oral and Nasal Delivery: Review of Recent Findings

N. Kamei, M. Takeda-Morishita, El-Sayed Khafagy, 2012 .

Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides.

Noriyasu Kamei, Kozo Takayama, Mariko Morishita, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.

N. Kamei, M. Morishita, K. Takayama, 2008, Journal of controlled release : official journal of the Controlled Release Society.

Cell-Penetrating Peptide Penetratin as a Potential Tool for Developing Effective Nasal Vaccination Systems.

N. Kamei, M. Takeda-Morishita, K. Takayama, 2016, Journal of pharmaceutical sciences.

Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction

N. Kamei, M. Takeda-Morishita, Nobuyuki Okada, 2018, Scientific Reports.

Antidiabetic Effects of Omega-3 Polyunsaturated Fatty Acids: From Mechanism to Therapeutic Possibilities

N. Kamei, M. Takeda-Morishita, Y. Iwase, 2015 .

Dependence of Intestinal Absorption Profile of Insulin on Carrier Morphology Composed of β-Cyclodextrin-Grafted Chitosan.

K. Ariga, N. Kamei, M. Takeda-Morishita, 2016, Molecular pharmaceutics.

Recent Advances in Brain Delivery Researches for Biopharmaceuticals

N. Kamei, Takeda Mariko, 2013 .

Noninvasive delivery of therapeutic peptides and proteins using cell-penetrating peptides

N. Kamei, M. Morishita, 2010 .

Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse.

N. Kamei, M. Takeda-Morishita, Rei Itokazu, 2017, Molecular pharmaceutics.

Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy.

Yasuyoshi Watanabe, N. Kamei, M. Takeda-Morishita, 2016, Molecular pharmaceutics.

Potential of single cationic amino acid molecule "Arginine" for stimulating oral absorption of insulin.

N. Kamei, M. Takeda-Morishita, El-Sayed Khafagy, 2017, International journal of pharmaceutics.

Optimization of the method for analyzing endocytosis of fluorescently tagged molecules: Impact of incubation in the cell culture medium and cell surface wash with glycine-hydrochloric acid buffer.

N. Kamei, M. Takeda-Morishita, I. Nakase, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Safety of the cell-penetrating peptide penetratin as an oral absorption enhancer.

N. Kamei, M. Takeda-Morishita, E. Nielsen, 2015, Biological & pharmaceutical bulletin.

The in vitro and in vivo study of novel formulation of Andrographolide PLGA nanoparticle embedded into gelatin-based hydrogel to prolong delivery and extend residence time in joint.

N. Kamei, M. Takeda-Morishita, K. Sathirakul, 2021, International journal of pharmaceutics.

Complexation hydrogels as potential carriers in oral vaccine delivery systems

N. Peppas, N. Kamei, M. Takeda-Morishita, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Comparative study of commercial protocols for high recovery of high-purity mesenchymal stem cell-derived extracellular vesicle isolation and their efficient labeling with fluorescent dyes.

N. Kamei, M. Takeda-Morishita, Hiro Hashimoto, 2021, Nanomedicine : nanotechnology, biology, and medicine.

Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.

Nicholas A Peppas, Noriyasu Kamei, Kozo Takayama, 2009, Journal of controlled release : official journal of the Controlled Release Society.

A universal method to analyze cellular internalization mechanisms via endocytosis without non‐specific cross‐effects

N. Kamei, I. Nakase, Chiaki Sugiyama, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Therapeutic effects of anti-amyloid β antibody after intravenous injection and efficient nose-to-brain delivery in Alzheimer’s disease mouse model

N. Kamei, M. Takeda-Morishita, T. Saido, 2022, Drug Delivery and Translational Research.

Investigation of the Transport Pathways Associated with Enhanced Brain Delivery of Peptide Drugs by Intranasal Coadministration with Penetratin

N. Kamei, M. Takeda-Morishita, T. Kanazawa, 2021, Pharmaceutics.

Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane

N. Kamei, M. Takeda-Morishita, El-Sayed Khafagy, 2015, The AAPS Journal.

Colonic delivery of docosahexaenoic acid improves impaired glucose tolerance via GLP-1 secretion and suppresses pancreatic islet hyperplasia in diabetic KK-A(y) mice.

N. Kamei, M. Takeda-Morishita, K. Takayama, 2013, International journal of pharmaceutics.

A novel approach using functional peptides for efficient intestinal absorption of insulin.

N. Kamei, M. Morishita, K. Takayama, 2007, Journal of controlled release : official journal of the Controlled Release Society.

In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.

Jørgen Olsen, N. Kamei, U. Rahbek, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Key functions in polymer carriers for intestinal absorption of insulin.

N. Kamei, A. Lowman, M. Morishita, 2008, International journal of pharmaceutics.

Noninvasive insulin delivery: the great potential of cell-penetrating peptides.

N. Kamei, M. Takeda-Morishita, El-Sayed Khafagy, 2013, Therapeutic delivery.

Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form.

N. Kamei, M. Takeda-Morishita, El-Sayed Khafagy, 2016, International journal of pharmaceutics.

Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.

N. Kamei, M. Takeda-Morishita, Chikako Shigei, 2018, Biological & pharmaceutical bulletin.

Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.

N. Kamei, M. Morishita, K. Takayama, 2009, International journal of pharmaceutics.

Systemic and brain delivery of leptin via intranasal coadministration with cell-penetrating peptides and its therapeutic potential for obesity.

N. Kamei, M. Takeda-Morishita, Serena Hirano, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.

N. Kamei, M. Takeda-Morishita, Y. Onuki, 2013, Journal of pharmaceutical sciences.

Microvillus-Specific Protein Tyrosine Phosphatase SAP-1 Plays a Role in Regulating the Intestinal Paracellular Transport of Macromolecules.

N. Kamei, M. Takeda-Morishita, T. Matozaki, 2017, Journal of pharmaceutical sciences.

Novel endogenous engineering platform for robust loading and delivery of functional mRNA by extracellular vesicles

N. Kamei, Dhanu Gupta, Virginia Castilla-Llorente, 2023, bioRxiv.

Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography.

Yasuyoshi Watanabe, N. Kamei, M. Morishita, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Combination Strategy with Complexation Hydrogels and Cell-Penetrating Peptides for Oral Delivery of Insulin.

N. Peppas, N. Kamei, M. Takeda-Morishita, 2018, Biological & pharmaceutical bulletin.

Development of Efficient Nose-to-Brain Delivery Technology for Treatment of Dementia with Biological Drugs

N. Kamei, 2023, Drug Delivery System.